Literature DB >> 1519391

[Comparative analysis of mezlocillin/metronidazole and amoxicillin/clavulanic acid as "one shot" preventive antibiotic administration in colorectal interventions].

E Löhde1, L Scholz, A Gemperle, H Langmark, W Hopfenmüller, O Abri, E Kraas.   

Abstract

The prophylactic effect of intraoperative "one shot" antibiotic application in colorectal surgery was investigated. Patients were randomised and the antibiotic combination Mezlocillin/Metronidazole (group A) or Amoxicillin/Clavulamid acid (group B) was applicated in 160 patients. 111 patients were selected for the study (group A: 59; group B: 52 patients). In the postoperative course 53% (group A) and 67% (group B) of the patients developed bacterial infections. Abdominal wound healing was complicated by infection in 15% (A) and 12% (B) of the patients. A significant difference between the two groups could not be proven, 24% of all patients with documented intraoperative bacterial contamination and 10% of the patients with negative findings developed wound infections. In colorectal surgery patients are still at high risk for infectious complications. Applicated antibiotics should basically cover aerobic and anaerobic germs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1519391

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  2 in total

1.  [Peritoneal and subcutaneous administration of cefazolin as perioperative antibiotic prophylaxis in colorectal operations. Prospective randomized comparative study of 200 patients].

Authors:  J Quendt; I Blank; W Seidel
Journal:  Langenbecks Arch Chir       Date:  1996

2.  Perioperative Standard Oral Nutrition Supplements Versus Immunonutrition in Patients Undergoing Colorectal Resection in an Enhanced Recovery (ERAS) Protocol: A Multicenter Randomized Clinical Trial (SONVI Study).

Authors:  Pedro Moya; Leticia Soriano-Irigaray; Jose Manuel Ramirez; Alessandro Garcea; Olga Blasco; Francisco Javier Blanco; Carlo Brugiotti; Elena Miranda; Antonio Arroyo
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.